BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26004540)

  • 1. Negative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme's Conformational Freedom and Disorder.
    Dellus-Gur E; Elias M; Caselli E; Prati F; Salverda ML; de Visser JA; Fraser JS; Tawfik DS
    J Mol Biol; 2015 Jul; 427(14):2396-409. PubMed ID: 26004540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.
    Marciano DC; Pennington JM; Wang X; Wang J; Chen Y; Thomas VL; Shoichet BK; Palzkill T
    J Mol Biol; 2008 Dec; 384(1):151-64. PubMed ID: 18822298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What makes a protein fold amenable to functional innovation? Fold polarity and stability trade-offs.
    Dellus-Gur E; Toth-Petroczy A; Elias M; Tawfik DS
    J Mol Biol; 2013 Jul; 425(14):2609-21. PubMed ID: 23542341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.
    Tomatis PE; Rasia RM; Segovia L; Vila AJ
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13761-6. PubMed ID: 16172409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pervasive Pairwise Intragenic Epistasis among Sequential Mutations in TEM-1 β-Lactamase.
    Gonzalez CE; Ostermeier M
    J Mol Biol; 2019 May; 431(10):1981-1992. PubMed ID: 30922874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
    Kather I; Jakob RP; Dobbek H; Schmid FX
    J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and
    Standley M; Blay V; Beleva Guthrie V; Kim J; Lyman A; Moya A; Karchin R; Camps M
    ACS Infect Dis; 2022 Dec; 8(12):2451-2463. PubMed ID: 36377311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
    Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
    J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins.
    Raquet X; Vanhove M; Lamotte-Brasseur J; Goussard S; Courvalin P; Frère JM
    Proteins; 1995 Sep; 23(1):63-72. PubMed ID: 8539251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
    Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
    J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
    De Wals PY; Doucet N; Pelletier JN
    Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein.
    Bershtein S; Segal M; Bekerman R; Tokuriki N; Tawfik DS
    Nature; 2006 Dec; 444(7121):929-32. PubMed ID: 17122770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network of epistatic interactions in an enzyme active site revealed by large-scale deep mutational scanning.
    Judge A; Sankaran B; Hu L; Palaniappan M; Birgy A; Prasad BVV; Palzkill T
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2313513121. PubMed ID: 38483989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
    Knies JL; Cai F; Weinreich DM
    Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
    Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
    J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.